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1. Introduction 
Factor B (B), a complement component of the 
alternative pathway, is known to be a precursor of 
alternative C3/C5 convertase. B is cleaved by factor 
(9) in the presence of C3 and Mg 2+ into two fragments, 
Bb and Ba [1]. C3b can be replaced by cobra venom 
factor (CVF). The bimolecular complex of CVF and 
B is converted to the active form CVF-Bb by D [2]. 
Activation of B by trypsin, plasmin and pronase 
instead of D has been reported [3]. In [4] trypsin 
cleaved B to form the CVF-Bb complex. However, 
the effect of CVF on cleavage of B by protease is
unknown. 
Here we investigated the mode of cleavage of B in 
the presence and absence of CVF by Hageman factor 
fragment (HFf), plasma kallikrein and plasmin, which 
are generated during contact activation. Sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) showed that plasma kallikrein cleaved 
B in the presence or absence of CVF into 2 fragments 
(M r 60 000, 38 000). A plasmin digest of B in the 
presence of CVF was similar to a kallikrein digest. In 
the absence of CVF, plasmin cleaved B to 4 fragments 
(M r 60 000, 48 000, 38 000, 30 000). HFf did not 
cleave B. Plasmin and kalikrein cleaved B and yielded 
the CVF-Bb complex in the presence of CVF, as 
shown by high-speed gel permeation chromatography. 
2. Materials and methods 
Human plasma was obtained from Japan Red Cross. 
Cobra venom (Na/a na/a kauthia) was purchased from 
Wako Pure Chemical Industries Ltd. 
2.1. Preparations of  various proteases, C3 and CVF 
B, D, C3, CVF, plasminogen and Hageman factor 
were purified as in [5-10]. Bb was isolated as in [1]. 
Plasmin was purified after activation with urokinase. 
HFf was isolated after incubation with Hageman fac- 
tor and purified kallikrein as in '[ I 0]. Plasma kallikrein 
was prepared as in [11] from spontaneously activated 
crude kallikrein. 
2 2. SDS-PA GE 
This was done as in [12] using 7% gel under non- 
reducing conditions. A sample of 20/~g B with or 
without CVF (molar ratio 1:1) in 0.02 M sodium 
phosphate buffer containing 0.15 M NaC1 and 0.01 M 
MgC12 was preincubated at 37°C for 5 min,then mixed 
with HFf, plasma kallikrein and plasmin, respectively, 
at an enzyme-substrate ratio of 1:30. After various 
incubation periods, samples of the mixture were sub- 
jected to SDS-PAGE. 
2.3 .Analysis by high-speed gel permeation chroma- 
tography ( GPC) 
The formation of a CVF-Bb complex was investi- 
gated by GPC (Hitachi 635A) on a column (0.75 × 
60 cm) of TSKG 3000 SW (Toyo Soda Manufacturing 
Co.) with 0.05 M sodium phosphate buffer (pH 7.4) 
containing 0.1 M NaC1 and 0.005 M EDTA as eluant 
at room temperature. The flow rate was adjusted to 
0 5 ml/min, and the absorbance at254 nm was mea- 
sured. The elution time of blue dextran in the void 
volume was 18.8 min and that of tyrosine in the bed 
volume was 46.6 rain. A mixture of CVF (20 gg) and 
B (20/~g) was preincubated at 37°C for 5 min in the 
presence of 0.005 M MgC12, and then plasmin (1 gg), 
kallikrein (1/~g) of D (0.25 ~g) was added, and incu- 
bation was continued at 37°C for 2 h. EDTA (final 
conc. 0.01 M) was added to the mixture (final vol. 
70 #1) after incubation, and a 50/~1 aliquot of the 
mixture was subjected to GPC. 
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3. Results and discussion 
The Mr-values of  B and CVF were estimated to be 
90 000 and 140 000, respectively, by SDS-PAGE 
(fig.la,b). B was converted to Bb (M r 60 000) and Ba 
(M r 38 000) by D in the presence of CVF (fig.1 c). 
CVF was resistant to plasma kallikrein and plasmin. 
When B was incubated with HFf  at 37°C for 3 h in 
the presence and absence of CVF, no significant cleav- 
age of  B was detected (fig.2). On the other hand, B 
was cleaved by plasma kallikrein both in the presence 
and absence of  CVF to two fragments o fM r 60 000 
and M r 38 000 corresponding to Bb and Ba, respec- 
tively, produced by D (fig.3). Both HFf  and plasma 
kallikrein have amidolytic activity on the synthetic 
substrate D-Pro-Phe-Arg-p-n i t roani l ide [ 10], while 
the spectrum of the synthetic substrate for kallikrein 
differs from that for HFf [10,13]. This difference 
seems to be related to the differences in the behaviors 
of kallikrein and HFf  with B. HFa, a high M r form of 
activated Hageman factor, is a more potent activator 
of factor XI than HFf  [14]. It would be interesting to 
know whether HFa cleaves B. 
Plasmin cleaved B to two fragments imilar to Bb 
and Ba in the presence of CVF (fig.4B). However, in 
the absence of  CVF, it cleaved B to 4 fragments 
(fig.4A). The apparent Mr-values of these fragments 
were 60 000,48 000,38 000 and 30 000, respectively. 
a b c d 
Fig.1. Cleavage of B by D in the presence of CVF on SDS- 
PAGE: 16 ~g B was incubated with 15 #g CVF and 0.25 ~g 
at 37°C for 1 h; (a) B, (b) CVF, (c) B incubated with CVF 
and D (d);M r standards (1) phosphorylase b, (2) bovine 
serum albumin, (3) ovalbumin, (4) carbonic anhydrase, (5) 
soybean trypsin inhibitor, (6) aqactalbumin. 
a b 
Fig.2. SDS-PAGE of an incubation mixture of B and HFf in 
the absence (a) and presence (b) of CVF. The arrow shows 
the position of HFf. 
Bb (M r 60 000) isolated from an incubation mixture 
of B, D and C3 was not cleaved by plasmin. The frag- 
ments o fM r 60 000 and 38 000 corresponded to Bb 
and Ba, but the materials in the fragments ofM r 48 000 
and 30 000 derived from B are still unknown. The 
NH2-terminal portions of the fragments must be deter- 
mined. 
B with CVF is likely to be cleaved at one point by 
plasmin. Without Mg 2÷, B was cleaved to 4 fragments 
even in the presence of  CVF. These results indicate 
that the points in B that are susceptible to cleavage 
are concealed when B forms a complex with CVF and 
Mg 2+. 
B is cleaved by D in the presence of CVF to form a 
complex CVF-Bb ,  an active C3/C5 convertase [15]. 
As described above, in the presence of CVF, B is 
cleaved by kallikrein and plasmin to 2 fragments. The 
formation of a complex of CVF with the M r 60 000 
fragment produced by kallikrein or plasmin was 
examined by GPC analysis. On GPC analysis, small 
amounts of  protein were detected rapidly. A mixture 
of B and CVF gave two peaks in the presence of EDTA 
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Fig.3. Cleavage of B by plasma kallikrein. (A) SDS-PAGE of B incubated for the following times with plasma kaUikrein in the 
absence of CVF: (a) 0 min, (b) 30 min, (c) 60 min, (d) 120 min, (e) 180 min. (B) In the presence of CVF: (a) 0 min, (b) 30 min, 
(c) 60 min, (d) 120 min, (e) 180 min;M r standards as in fig.1. 
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Fig.4. Cleavage of B by plasmin. (A) SDS-PAGE of B incubated for the following times with plasmin in the absence of CVF: (a) 
15 min, (b) 30 min, (c) 60 min, (d) 120 min, (e) 180 min. (B) In the presence of CVF: (a) 15 min, Co) 30 min, (c) 60 min, (d) 
120 min, (e) 180 min. (C) (a) B, (b) CVF, (c).M r standards as in rigA. 
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Fig.5. Elution pattern on high speed gel permeation chroma- 
tography (GPC). The reaction mixture was incubated for 2 h 
at 37°C and applied to GPC: (A) B + CVF; (B) B + CVF + D; 
(C) B + CVF + plasmin; (D) B + CVF + plasma kallikrein; 
(a-d) were concluded to be B, CVF, Ba and CVF-Bb, respec- 
tively. 
(fig.5A). The elution time of B was 27.0 min and that 
of CVF was 25.3 min. A mixture of B, CVF, MgC12 
and D was incubated at 37°C for 2 h, and then EDTA 
was added, and an aliquot was subjected to GPC 
(fig.5B). The 3 peaks eluted at 23.6 rain, 27.0 min 
and 31.5 rain were concluded to be those of CVF-Bb,  
remaining B, and Ba, respectively. The elution patterns 
of mixtures of B, CVF, MgC12 and plasmin or kalli- 
krein are shown in fig.5C,D. Each mixture was mixed 
with EDTA before GPC. Four peaks were eluted at 
23.6 min, 25.3 min, 27.5 min and 31.5 min. This 
result shows the formation of a complex of CVF and 
B fragment produced by plasmin or kaUikrein. 
Here, plasmin and plasma kallikrein cleaved B in 
the absence of CVF. In the presence of CVF, B was 
cleaved by plasmin or kallikrein to a compound form- 
ing a complex with CVF, indicating activation of B in 
the purified system. However, in [16] low hemolytic 
activity of plasmin was shown in the alternative com- 
plement pathway. In [5] aM r 47 000 fragment of B 
was suggested in serum. This fragment seems to corre- 
spond with the M r 48 000 fragment obtained on 
digestion of plasmin without CVF here. Although it is 
unknown at present whether the participation of plas- 
rain and kallikrein in the alternative complement 
pathway results in activation or degradation of B in 
the plasma, a significant change of B seems to occur 
on contact activation with the Hageman factor. 
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